Article Information
History
- January 4, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nawal AlKaabi, MBBS*,1,2,
- Yun Kai Yang*,3,
- Jing Zhang, BS*,6,
- Ke Xu, PhD*,6,
- Yu Liang, MS4,5,
- Yun Kang, MS4,5,
- Ji Guo Su, PhD4,5,
- Tian Yang, MS3,
- Salah Hussein, MBBS1,
- Mohamed Saif ElDein1,
- Shuai Shao, MS4,5,
- Sen Sen Yang, MS4,5,
- Wenwen Lei, PhD6,
- Xue Jun Gao7,
- Zhiwei Jiang8,
- Hui Wang9,
- Meng Li3,
- Hanadi Mekki Mekki10,
- Walid Zaher, PhD11,
- Sally Mahmoud, PhD11,
- Xue Zhang3,
- Chang Qu3,
- Dan Ying Liu3,
- Jing Zhang, PhD4,5,
- Mengjie Yang, MS6,
- Islam ElTantawy, PhD11,
- Peng Xiao11,
- Zhao Nian Wang3,
- Jin Liang Yin3,
- Xiao Yan Mao7,
- Jin Zhang8,
- Ning Liu, MS4,5,
- Fu Jie Shen, MS4,
- Liang Qu3,
- Yun Tao Zhang, PhD†,3,
- Prof Xiao Ming Yang, MS†,3,
- Prof Guizhen Wu, MS†,6 and
- Prof Qi Ming Li, PhD†,4,5,*
- 1Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
- 2College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
- 3China National Biotec Group Company Limited, Beijing, China
- 4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
- 5National Engineering Center for New Vaccine Research, Beijing, China
- 6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
- 7Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
- 8Beijing KeyTech Statistical Consulting Co.,Ltd, Beijing, China
- 9Beijing Institute of Biological Products Company Limited, Beijing, China
- 10Union 71, United Arab Emirates
- 11G42 Healthcare, IROS (Insights Research Organization & Solutions), United Arab Emirates
- ↵*Corresponding author; email: liqiming189{at}163.com